Singapore markets close in 2 hours 40 minutes

Harbin Pharmaceutical Group Co., Ltd. (600664.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
2.6200-0.0500 (-1.87%)
As of 02:05PM CST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,667,189
15,456,578
13,808,761
12,802,016
10,788,457
Cost of revenue
11,424,227
11,404,770
10,402,693
9,766,068
8,441,040
Gross profit
4,242,962
4,051,808
3,406,068
3,035,947
2,347,416
Operating expenses
Research development
98,220
106,015
115,805
97,733
92,527
Selling general and administrative
2,645,398
2,489,581
1,894,515
1,476,621
1,303,067
Total operating expenses
3,437,456
3,291,556
2,746,073
2,444,477
2,925,110
Operating income or loss
805,506
760,251
659,995
591,470
-577,694
Interest expense
54,397
56,468
85,535
105,155
58,269
Income before tax
708,051
650,540
701,154
630,534
-968,648
Income tax expense
183,514
176,322
188,942
220,689
76,602
Income from continuing operations
524,537
474,218
512,212
409,846
-1,045,250
Net income
449,712
395,263
465,150
371,084
-1,077,699
Net income available to common shareholders
449,712
395,263
465,150
371,084
-1,077,699
Basic EPS
0.25
0.16
0.19
0.15
-0.43
Diluted EPS
0.24
0.16
0.18
0.15
-0.43
Basic average shares
2,304,442
2,470,396
2,448,159
2,473,892
2,506,278
Diluted average shares
2,440,219
2,470,396
2,584,168
2,473,892
2,506,278